Trexquant Investment LP bought a new position in MultiPlan Co. (NYSE:MPLN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 41,273 shares of the company's stock, valued at approximately $610,000. Trexquant Investment LP owned about 0.26% of MultiPlan at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in MPLN. Beach Point Capital Management LP lifted its stake in shares of MultiPlan by 9.2% in the 4th quarter. Beach Point Capital Management LP now owns 384,982 shares of the company's stock worth $5,690,000 after purchasing an additional 32,582 shares during the period. Oppenheimer & Co. Inc. bought a new position in MultiPlan in the fourth quarter worth approximately $292,000. Empowered Funds LLC boosted its stake in shares of MultiPlan by 5.0% during the 4th quarter. Empowered Funds LLC now owns 46,191 shares of the company's stock worth $683,000 after acquiring an additional 2,188 shares during the last quarter. Prudential Financial Inc. bought a new stake in shares of MultiPlan during the 4th quarter valued at $2,494,000. Finally, Geode Capital Management LLC grew its position in shares of MultiPlan by 17.3% during the 4th quarter. Geode Capital Management LLC now owns 67,615 shares of the company's stock valued at $1,000,000 after acquiring an additional 9,954 shares during the period. Institutional investors own 87.15% of the company's stock.
MultiPlan Price Performance
NYSE:MPLN traded down $1.20 during trading hours on Thursday, hitting $20.32. 54,598 shares of the stock traded hands, compared to its average volume of 112,759. The stock has a 50 day moving average price of $21.89 and a 200 day moving average price of $14.74. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 21.73. The company has a market cap of $328.59 million, a price-to-earnings ratio of -0.21 and a beta of 0.13. MultiPlan Co. has a 1 year low of $4.80 and a 1 year high of $31.01.
Analysts Set New Price Targets
Separately, Citigroup lifted their target price on MultiPlan from $10.00 to $12.50 and gave the company a "neutral" rating in a research report on Friday, January 10th.
Check Out Our Latest Analysis on MultiPlan
About MultiPlan
(
Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Featured Articles
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
